Tumor growth of suspected meningiomas in clinically healthy 80-year-olds: A follow up five years later

Zentralblatt fur Neurochirurgie

Volumn 69, Issue 4, 2008, Pages 182-186

  Krampla, Wolfgang ^a   Newrkla, S ^a   Pfisterer, W ^a   Jungwirth, S ^b   Fischer, P ^c   Leitha, T ^a   Hruby, W ^a   Tragl, K H ^b  

^a DANUBE HOSPITAL   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Elderly; Meningioma; Tumor growth

Indexed keywords

AGE; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FOLLOW UP; HUMAN; INCIDENCE; MENINGIOMA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGIC TEST; SURGICAL RISK; TUMOR GROWTH; TUMOR VOLUME; WATCHFUL WAITING;

AGED, 80 AND OVER; COHORT STUDIES; CONTRAST MEDIA; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MENINGIOMA; NEUROSURGICAL PROCEDURES;

EID: 57149085279     PISSN: 00444251     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1080940     Document Type: Article

References (18)

1. Anderson GF, Hussey PS. Population aging: a comparison among industrialized countries. Health Affairs 2000: 19 (3): 191-203
2. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 1996; 29 (3): 197 PubMed-205
3. Caroli M, Locatelli M, Prada F et al. Surgery for intracranial meningiomas in the elderly: a clinical-radiological grading system as a predictor of outcome. J Neurosurg 2005; 102 (2): 290 PubMed-294
4. Claus EB, Bondy ML, Schildkraut JM et al. Epidemiology of intracranial meningioma. Neurosurgery 2005; 6: 57
5. D'Andrea G, Roperto R, Caroli E. Thirty-seven cases of intracranial meningiomas in the ninth decade of life: our experience and review of the literature. Neurosurgery 2005: 56 (5): 956-961
6. Firsching R, Fischer A, Peters R et al. Growth rate of incidental meningiomas. J Neurosurg 1990; 73 (4): 545-547
7. Fischer P, Jungwirth S, Krampla W et al. Vienna-Transdanube-Aging "VITA": Study design, recruitment strategies and level of participation. J Neural Transm Suppl 2002; 62: 103-114 PubMed
8. Friend KE, Radinsky R, MacCutcheon IE. Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist. J Neurosurg 1999; 91 (1): 93-99
9. Glick R, Unterman T, Woude M Van der et al. Insulin and insulin-like growth factors in central nervous system tumors. Part V: Production of insulin-like growth factors I and II in vitro. J Neurosurg 1992; 77 (3): 445-450
10. Krampla W, Newrkla S, Pfisterer W et al. Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the Transdanube Ageing Study (VITA). Cancer 2004; 15: 1208-1212 PubMed
11. Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. Neurosurg 2000; 92 (5): 766-770 PubMed
12. Longstreth WT, Dennis LK, MacGuire VM et al. Epidemiology of intracranial meningioma. Cancer 1993; 72 (3): 639-648 PubMed
13. Manton KG. The dynamics of population aging: demography and policy analysis. Milbank Q 1991; 69 (2): 309-338
14. Nakasu S, Hirano A, Shimura T et al. Incidental meningeomas in autopsy study. Surg Neurol 1987; 27 (4): 319-322 PubMed
15. Olivero W, Lister J, Elwood P. The natural history and growth rate of asymptomatic meninigiomas: a review of 60 patients. J Neurosurg 1995; 83 (2): 222-224
16. Staneczek W, Janisch W. Epidemiologic data on meningeomas in East Germany 1961-1986: incidence, localization, age and sex distribution. Clin Neuropathol 1992; 11 (3): 135-141 PubMed
17. Tuljapurkar S, Li N, Boe C. A universal pattern of mortality decline in the G7 countries. Nature 2000; 405: 789-792 PubMed
18. Yano S, Kuratsu J, Kumamoto. Brain Tumor Research Group Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 2006; 105 (4): 538-543 PubMed